Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-27

Clinical Trial Update: Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating immune persistence after a one-dose freeze-dried live attenuated varicella vaccine in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varicella vaccine (live attenuated) - freeze-dried single-dose formulation (varicella vaccine, live attenuated)

Snippet

Sponsor: Changchun Changsheng Life Science and Technology Co., Ltd. | Conditions: Chickenpox | Phase 4 | Status: UNKNOWN